After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Zenas Biopharma Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Zenas Biopharma Inc is $407.46M. A total of 0.16 million shares were traded on the day, compared to an average of 289.79K shares.
In the most recent transaction, MOULDER LEON O JR bought 45,000 shares of ZBIO for 9.98 per share on Dec 04 ’24. After the transaction, the Chief Executive Officer now owns 241,155 company shares. In a previous transaction on Dec 03 ’24, MOULDER LEON O JR bought 25,000 shares at 10.76 per share. ZBIO shares that Chief Executive Officer owns now total 196,155.
Among the insiders who bought shares, MOULDER LEON O JR acquired of 7,500 shares on Nov 18 ’24 at a per-share price of $15.00. This resulted in the Chief Executive Officer holding 168,655 shares of ZBIO after the transaction. In another insider transaction, MOULDER LEON O JR bought 2,500 shares at $14.57 per share on Nov 19 ’24. Company shares held by the Chief Executive Officer now total 171,155.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ZBIO has a high of $26.25 and a low of $8.33.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZBIO is Buy with a score of 5.00.
